| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/06/2002 | EP1176984A2 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates |
| 02/06/2002 | EP1176982A1 Prucalopride oral solution |
| 02/06/2002 | EP1176975A1 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 02/06/2002 | EP1176974A1 Compositions and methods for treating benign prostatic hyperplasia using tocotrienols |
| 02/06/2002 | EP1176972A1 Use of phyllanthus for targeted stimulation of the immune system |
| 02/06/2002 | EP1176971A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 02/06/2002 | EP1176969A2 Substitution infusion fluid and citrate anticoagulation |
| 02/06/2002 | EP1176968A2 Selenium-containing pro-drugs for cancer therapy |
| 02/06/2002 | EP1176967A1 Management of pain after joint surgery |
| 02/06/2002 | EP1176966A2 Oligodeoxynucleotide and its use to induce an immune response |
| 02/06/2002 | EP1176965A1 Antisense modulation of fas mediated signaling |
| 02/06/2002 | EP1176964A1 Compositions and uses of et743 for treating cancer |
| 02/06/2002 | EP1176963A2 Use of dopamine d 3? receptor ligands for producing medicaments for treating kidney disorders |
| 02/06/2002 | EP1176962A2 Liposome compositions for improved drug retention |
| 02/06/2002 | EP1176961A2 Nicotine delivery systems |
| 02/06/2002 | EP1176960A1 Synergistic combination comprising roflumilast and a pde-3 inhibitor |
| 02/06/2002 | EP1176959A1 Novel prolines as antimicrobial agents |
| 02/06/2002 | EP1176958A1 Novel catechols as antimicrobial agents |
| 02/06/2002 | EP1176957A1 Method for treating abnormal cell proliferation in the brain |
| 02/06/2002 | EP1176956A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/06/2002 | EP1176955A1 Cardioprotective composition and uses thereof |
| 02/06/2002 | EP1176954A1 Neuroprotective composition and uses thereof |
| 02/06/2002 | EP1176953A2 Treatment of a variety of pathological conditions, including spasticity and convulsions, by effecting modulation of cns activity with isovaleramide, isovaleric acid, or a related compound |
| 02/06/2002 | EP1176952A2 2r,4s-hydroxyitraconazole isomers |
| 02/06/2002 | EP1176951A1 Drug delivery device |
| 02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
| 02/06/2002 | EP1176933A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |
| 02/06/2002 | EP1176877A1 Methods for lowering viscosity of glucomannan compositions |
| 02/06/2002 | EP1176870A2 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 02/06/2002 | EP1052987B1 Tablets to be crunched or sucked, comprising iron as active principle |
| 02/06/2002 | EP1001775B1 Medicine containing yohimbine and arginine for treating erectile dysfunction |
| 02/06/2002 | EP1001773B1 Oral solid pharmaceutical compositions containing nicorandil for a modulated release and the process for their preparation |
| 02/06/2002 | EP0971917B1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 02/06/2002 | EP0966256B1 Agents for promoting oral hygiene and oral health |
| 02/06/2002 | EP0931084B1 1,3-dicarboxylic germanium complex and its therapeutic use |
| 02/06/2002 | EP0912507B1 Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension |
| 02/06/2002 | EP0900077B1 Use of a toremifene metabolite for lowering serum cholesterol level. |
| 02/06/2002 | EP0892794B1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 02/06/2002 | EP0891325B1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists |
| 02/06/2002 | EP0888276B1 Cinnamylidene camphor derivatives and their use as uv-a protecting agents |
| 02/06/2002 | EP0882024B1 Retroviral protease inhibiting compounds |
| 02/06/2002 | EP0878198B1 Tablets containing an anion exchange resin |
| 02/06/2002 | EP0866865B1 Chimeric oligomers having an rna-cleavage activity |
| 02/06/2002 | EP0863882B1 Amino substituted pyrimidines and triazines |
| 02/06/2002 | EP0861077B1 Hemoregulatory compounds |
| 02/06/2002 | EP0855908B1 Dietary regimen of nutritional supplements for relief of symptoms of arthritis |
| 02/06/2002 | EP0845991B1 Use of phenol substituted diphosphonates as antineoplastic agents |
| 02/06/2002 | EP0843551B1 Endothelin receptor antagonists |
| 02/06/2002 | EP0836605B1 Pyrrolopyrimidines and processes for the preparation thereof |
| 02/06/2002 | EP0800392B1 Pharmaceutical preparations containing nifedipine and process for producing it |
| 02/06/2002 | EP0790824B1 2,2-dichloroalkane carboxylic acids, process for preparing the same, medicament containing the same, and use thereof for treating insulin resistance |
| 02/06/2002 | EP0783490B1 1-acyl-4-aliphatic aminopiperidine compounds |
| 02/06/2002 | EP0781561B1 Novel medicinal use of 5ht 3 antagonist |
| 02/06/2002 | EP0777487B1 Treatment of stroke associated with macrophage infiltration |
| 02/06/2002 | EP0776663B1 Remedy for myotonic dystrophy |
| 02/06/2002 | EP0772598B1 Preparation of heterocyclic- and carbocyclic-substituted benzoic acids |
| 02/06/2002 | EP0771198B1 Dihydro-2,3-benzodiazepine derivatives |
| 02/06/2002 | EP0764028B1 Method of treating retained pulmonary secretions |
| 02/06/2002 | EP0762888B1 Copolymer-1 improvements in compositions of copolymers |
| 02/06/2002 | EP0734386B1 Platelet activating factor antagonists: imidazopyridine indoles |
| 02/06/2002 | EP0731694B1 Opioid formulations for treating pain |
| 02/06/2002 | EP0730448B1 Use of nitric oxide synthase substrate and/or donor, or a nitric oxide inhibitor for the manufacture of medicaments for the treatment of uterine contractility disorders |
| 02/06/2002 | EP0730441B1 Desquamation compositions containing salicylic acid and zwitterionic compounds |
| 02/06/2002 | EP0729354B1 Farnesyl derivatives and pharmaceutical compositions containing them |
| 02/06/2002 | EP0729353B1 Preparation of biodegradable microparticles containing a biologically active agent |
| 02/06/2002 | EP0728138B1 Anthracycline derivatives |
| 02/06/2002 | EP0712936B1 Low-molecular dna from sturgeon milt, a method of obtaining the dna and a pharmaceutical preparation based on it |
| 02/06/2002 | EP0688219B1 Reduction of boar odor in meat |
| 02/06/2002 | EP0679081B1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation |
| 02/06/2002 | EP0659082B1 Use of cytochrome p450 inhibitors for inhibiting the metabolism of nitrogen substituted acridine |
| 02/06/2002 | CN1334921A PGT and apoptosis |
| 02/06/2002 | CN1334878A Polynucleotide comprising ubiquitous chromatin opening element (UCDE) |
| 02/06/2002 | CN1334875A Cell signalling polypeptides and nucleic acids |
| 02/06/2002 | CN1334830A Hydrophilic ampholytic polymer |
| 02/06/2002 | CN1334820A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334819A Connective tissue growth factor fragments and methods and uses thereof |
| 02/06/2002 | CN1334816A Triazolo (4,5-D) pyrimidine compounds |
| 02/06/2002 | CN1334815A Methotrexate derivatives |
| 02/06/2002 | CN1334814A Antiviral nucleoside analogues |
| 02/06/2002 | CN1334813A Method for preparing (R)-(+)-3-{1-[2-(4-benzoyl-2-(3,4-difluorophenyl) morpholin-2-yl)ethyl]-4-phenylpiperdin-4-yl}-1,1-dimethylurea, its salts solvates and/or hydrates |
| 02/06/2002 | CN1334812A Piperazine derivatives |
| 02/06/2002 | CN1334811A Tricyclic farnesyl protein transferase inhibitors |
| 02/06/2002 | CN1334809A Nonsteroidal antiinflammatories |
| 02/06/2002 | CN1334808A Benzamide derivs. and their use as APOB-100 secretion inhibitors |
| 02/06/2002 | CN1334807A 1-heterocycle substd. diarylamines |
| 02/06/2002 | CN1334806A Beta-amide and beta-sulfonamide carboxylic acid derivs., their preparation and their use as endothelin receptor antagonists |
| 02/06/2002 | CN1334804A Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334802A Ligands of nuclear receptor |
| 02/06/2002 | CN1334801A Biphenyl and biphenyl-analogous compounds as integrin antagonists |
| 02/06/2002 | CN1334800A 3,4,5-trisubstd. aryl nitrone compounds and pharmaceutical compositions contg. same |
| 02/06/2002 | CN1334798A Phenylglycine derivatives |
| 02/06/2002 | CN1334797A 3,4-diamino-3-cyclobutene-1,2-dione derivs. which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/06/2002 | CN1334741A 肽的用途 Use of a peptide |
| 02/06/2002 | CN1334740A Method for providing nutraceutical or phytoceutical benefits and inhibiting oxidation using cherry derivatives |
| 02/06/2002 | CN1334738A Cerebrovascular regeneration/reconstruction promoters and nerve tissue secondary degeneration inhibitors comprising ginsenoside Rb1 |
| 02/06/2002 | CN1334737A Aciclovir compositions contg. dimethicone |
| 02/06/2002 | CN1334736A Modulation of immune response by ribavirin |
| 02/06/2002 | CN1334735A Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof |
| 02/06/2002 | CN1334734A Triphasic oral contraceptive |
| 02/06/2002 | CN1334732A Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia |